Minecraft developer Mojang is switching the Java Edition's graphics API from OpenGL to Vulkan ahead of its Vibrant Visuals update.
Work continues for the Vibrant Visuals update to come to Minecraft Java, and as part of that they're switching the rendering from OpenGL to Vulkan.
Thanks to progress in the company’s growth initiatives and cost management, Sysco (SYY) now expects profitability in FY26 to be at the upper end of the company’s previously issued guidance and local ...
A new firmware update for PS5 and PS5 Pro consoles has today been pushed out by Sony around the globe. Typically, most new PS5 updates don’t tend to do very much. Other than improving the overall ...
Sophie Nélisse as Teen Shauna in Yellowjackets, episode 10, season 3, streaming on Paramount+ with SHOWTIME, 2025. Photo Credit: Kailey Schwerman/Paramount+ with SHOWTIME. Image via Kailey ...
How to turn Minecraft into one of these popular games ...
Behind the president’s consequential first year back in office is a strategic decision to choose loyal aides and keep Congress on his side. As part of our video series on Trump’s second term, The Wall ...
Learn the best level for mining Diamonds in Minecraft 1.21, as well as tips on the best method for strip-mining, and other ...
Both Wuthering Waves 3.0 and 3.1 come with two new 5-star characters, with Lynae and Mornye in 3.0, and Aemeath and Luuk Herssen in version 3.1. Here's the WuWa 3.1 release date and maintenance end ...
LOS ANGELES—Kiran Gollapudi got lucky before his flight to Las Vegas took off on Saturday. The urologist nabbed a roomy exit-row seat on Southwest Airlines despite a mediocre boarding position, thanks ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
OCALA, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive data in a year-end update from the ongoing Phase 2 clinical ...